Dowling & Yahnke LLC Oncternal Therapeutics, Inc. Call Options Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ONCT
# of Institutions
4Shares Held
362KCall Options Held
0Put Options Held
0About Oncternal Therapeutics, Inc.
- Ticker ONCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,517,200
- Market Cap $396M
- Description
- Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...